276 related articles for article (PubMed ID: 28927899)
41. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
[TBL] [Abstract][Full Text] [Related]
42. [Gestational trophoblastic neoplasia after spontaneous normalization of human chorionic gonadotropin in patient with partial hydatidiform mole].
Matos M; Ferraz L; Lopes Pde F; Lozoya C; Amim Junior J; Rezende-Filho J; Braga A
Rev Bras Ginecol Obstet; 2015 Jul; 37(7):339-43. PubMed ID: 26247255
[TBL] [Abstract][Full Text] [Related]
43. Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.
Braga A; Canelas AC; Torres B; Maesta I; Giongo Pedrotti L; Bessel M; Vieira Dos Santos Esteves AP; Amim Junior J; Rezende Filho J; Elias KM; Horowitz NS; Berkowitz RS
PLoS One; 2022; 17(12):e0277892. PubMed ID: 36454778
[TBL] [Abstract][Full Text] [Related]
44. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
45. Incidence and outcome of gestational trophoblastic disease in lower Egypt.
Zakaria A; Hemida R; Elrefaie W; Refaie E
Afr Health Sci; 2020 Mar; 20(1):73-82. PubMed ID: 33402895
[TBL] [Abstract][Full Text] [Related]
46. Follow-Up After Molar Pregnancy Evacuation: Feasibility of Using Semi-Quantitative Urine Pregnancy Tests.
Hoppenot C; Zimmerman L; Arlandson M; Lurain JR; Patel A
J Reprod Med; 2016; 61(5-6):192-6. PubMed ID: 27424357
[TBL] [Abstract][Full Text] [Related]
47. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
48. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.
Balachandran K; Salawu A; Ghorani E; Kaur B; Sebire NJ; Short D; Harvey R; Hancock B; Tidy J; Singh K; Sarwar N; Winter MC; Seckl MJ
Gynecol Oncol; 2019 Oct; 155(1):8-12. PubMed ID: 31375268
[TBL] [Abstract][Full Text] [Related]
49. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
[TBL] [Abstract][Full Text] [Related]
50. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
[TBL] [Abstract][Full Text] [Related]
51. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
[TBL] [Abstract][Full Text] [Related]
52. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
53. Predictive values of different forms of human chorionic gonadotropin in postmolar gestational trophoblastic neoplasia.
Kimiaee P; Ashrafi-vand S; Mansournia MA; Bakhtiyari M; Mirzamoradi M; Bakhtiyari Z
Int J Gynecol Cancer; 2014 Nov; 24(9):1715-22. PubMed ID: 25340296
[TBL] [Abstract][Full Text] [Related]
54. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
Curry SL; Schlaerth JB; Kohorn EI; Boyce JB; Gore H; Twiggs LB; Blessing JA
Am J Obstet Gynecol; 1989 Apr; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
[TBL] [Abstract][Full Text] [Related]
55. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
56. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
[TBL] [Abstract][Full Text] [Related]
57. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
[TBL] [Abstract][Full Text] [Related]
58. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
59. Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia.
Soares RR; Maestá I; Colón J; Braga A; Salazar A; Charry RC; Sun SY; Goldstein DP; Berkowitz RS
Gynecol Oncol; 2016 Sep; 142(3):496-500. PubMed ID: 27423380
[TBL] [Abstract][Full Text] [Related]
60. Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review.
Costa HL; Doyle P
Gynecol Oncol; 2006 Mar; 100(3):579-85. PubMed ID: 16297971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
